Nuclear imaging in the management of thyroid carcinoma

Thyroid

Volumn 6, Issue 5, 1996, Pages 485-492

  Cavalieri, Ralph R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; IODINE 123; IODINE 131; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; THYROGLOBULIN;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; IODINE 131 UPTAKE TEST; METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

EID: 0029907825     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1996.6.485     Document Type: Review

References (55)

1. Mallin WH, Abdelhamid HE, Maxon HR 1994 Imaging modalities in the follow-up of non-iodine avid thyroid carcinoma. Am J Otolaryng 15:417-422.
2. Hurley JR, Becker DV 1988 Treatment of thyroid carcinoma with radioiodine. In: Gottschalk A, Hoffer PB, Potchen EJ (eds) Diagnostic Nuclear Medicine, 2nd ed. Williams & Wilkins, Baltimore, pp 792-814.
3. Maxon HR, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clinics N Am 19:685-719.
4. Dulgeroff AJ, Hershman JM 1994 Medical therapy for differentiated thyroid carcinoma. Endocrine Rev 15:500-515.
5. Meier CA, Braverman LE, Ebner SA, et al. 1994 Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J Clin Endocrinol Metab 78:188-196.
6. 131I ablation of thyroid remnants. Clin Nucl Med 8:123-126.
7. Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J 1988 A simplified low iodine diet in 1-131 scanning and therapy of thyroid cancer. Clin Nucl Med 13:866-868.
8. Cavalieri RR, McDougall IR 1996 In vivo isotopic tests and imaging. In: Braverman LE, Utiger RD (eds) The Thyroid: A Fundamental and Clinical Text, 7th ed. Lippincott, Philadelphia, pp. 352-376.
9. Seabold JE, Ben-Haim S, Pettit WA, et al. 1993 Diuretic-enhance 1-131 clearance after ablation therapy for differentiated thyroid cancer. Radiology 187:839-842.
10. Rawson RW, Rall JE, Peacock W 1951 Limitations in the treatment of cancer of the thyroid with radioactive iodine. J Clin Endocrinol Metab 11:1128-1131.
11. Park H-M 1992 Stunned thyroid after high-dose 1-131 imaging. Clin Nucl Med 17:501-502.
12. Park HM, Perkins OW, Edmondson JW, et al. 1994 Influence of diagnostic radioiodines on the uptake of ablative dose of Iodine-131. Thyroid 4:49-54.
13. Jeevanram RK, Shah DH, Sharma SM, Ganatra RD 1986 Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 13:277-279.
14. Maxon HR, Thomas SR, Washburn LC, Hinnefeld JD 1993 High-activity 1-123 for the diagnostic-evaluation of patients with thyroid cancer. J Nucl Med 34:42P.
15. Waxman A, Ramanna L, Chapman N, et al. 1981 The significance of 1-131 scan dose in patients with thyroid cancer: Determination of ablation: Concise Communication. J Nucl Med 22:861-865.
16. Arnstein NB, Carey JE, Spaulding SA, Sisson JC 1986 Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer. J Nucl Med 27:1764-1769.
17. Ramanna L, Waxman AD, Brachman MB, et al. 1985 Treatment rationale in thyroid carcinoma: Effect of scan dose. Clin Nuclear Med 10:687-689.
18. Maxon HR, Thomas SR, Hertzberg VS, et al. 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937-941.
19. Comtois R, Theriault C, Del Vecchio P 1993 Assessment of the efficacy of Iodine-131 for thyroid ablation. J Nucl Med 34:1927-1930.
20. Spies WG, Wojtowicz CH, Spies SM, Shah AY, Zimmer AM 1989 Value of post-therapy whole-body 1-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 1-131 therapy. Clin Nucl Med 14:793-800.
21. Pacini F, Lippi F, Formica N, et al. 1987 Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888-1891.
22. Sherman SI, Tielens ET, Sostre S, Wharam MDJ, Ladenson PW 1994 Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 78:629-634.
23. Norby EH, Neutze J, Van Nostrand D, Burman KD, Warren RW 1990 Nasal radioiodine activity: A prospective study of frequency, intensity, and pattern. J Nucl Med 31:52-54.
24. Bakheet S, Hammami MM 1993 Spurious lung metastases on radioiodine thyroid and whole body imaging. Clin Nucl Med 18:307-312.
25. McDougall IR 1995 Whole-body scintigraphy with radioiodine-131: A comprehensive list of false-positives with some examples. Clin Nucl Med 20:869-875.
26. Maayan ML, Eisenberg J, Lopez EM, Rothschild MA 1976 Hepatic visualization after 1-131 in patients with thyroid carcinoma. N Engl J Med 295:1258-1259.
27. Rosenbaum RC, Johnston GS, Valente WA 1988 Frequency of hepatic visualization during 1-131 imaging for metastatic thyroid carcinoma. Clin Nucl Med 13:657-660.
28. Hammami MM, Bakheet S 1996 Radioiodine breast uptake in nonbreastfeeding women: Clinical and scintigraphic characteristics. J Nucl Med 37:26-31.
29. Bakheet SM, Hammami MM 1994 False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 19:325-329.
30. O'Doherty MJ, Nunan TO, Croft DN 1993 Radionuclides and therapy of thyroid cancer. Nucl Med Commun 14:736-755.
31. Mishigishi T, Mizukami Y, Shuke N, et al. 1993 Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 20:75-79.
32. Veronikis IE, Simpkin PH, Braverman LE 1995 Uptake of 1-131 in the anterior mediastinum in thyroidectomized patients with differentiated thyroid cancer. J Invest Med 43:226A.
33. Pochin EE 1967 Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 18:113-135.
34. Tonami N, Hisada K 1980 T1-201 scintigraphy in postoperative detection of thyroid cancer: A comparative study with 1-131. Radiology 136:461-464.
35. Nemec J, Zamrazil V, Pohunkova D, Rohling S 1984 The rational use of T1-201 scintigraphy in the evaluation of differentiated thyroid cancer. Eur J Nucl Med 9:261-264.
36. Hoefnagel CA, Delprat CC, Marcuse HR, de Vijlder JJM 1986 Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 27:1854-1857.
37. Brendel AJ, Guyat M, Jeandot R, et al. 1988 Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 29:1515-1520.
38. Burman KD, Anderson JH, Wartofsky L, et al. 1990 Management of patients with thyroid carcinoma: Application of thallium-201 scintigraphy and magnetic resonance imaging. J Nucl Med 31:1958-1964.
39. Dadparvar S, Krishna L, Brady LW, et al. 1993 The role of Iodine-131 and Thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 71:3767-3773.
40. Charkes ND, Vitti RA, Brooks K 1990 Thallium-201 SPECT increases detectability of thyroid cancer metastases. J Nucl Med 31:147-153.
41. Ramanna L, Waxman A, Braunstein G 1991 Thallium-201 scintigraphy in differentiated thyroid cancer: Comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 32:441-446.
42. Iida Y, Hidaka A, Hatabu H, Kasagi K, Konishi J 1991 Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement. J Nucl Med 32:2098-2100.
43. Van Sorge-Van Boxel RAJ, Van Eck-Smit BLF, Goslings BM 1993 Comparison of serum thyroglobulin, 1-131 and T1-201 scintigraphy in the post-operative follow-up of differentiated thyroid cancer. Nucl Med Commun 14:365-372.
44. Schlumberger M, Tubiana M, De Vathaire F, et al. 1986 Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960-967.
45. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 80:1488-1492.
46. Zak IT, Seabold JE, Gurll NJ 1994 Tc-99m MIBI scintigraphic detection of metastatic insular thyroid carcinoma. Clin Nucl Med 20:31-36.
47. Sundram FX, Goh ASW, Ang ES 1993 Role of technetium-99m sestamibi in localization of thyroid cancer metastases. Ann Acad Med (Singapore) 22:557-559.
48. Yen TC, Lin HD, Lee CH, Chang SL, Yeh SH 1994 The role of technetium-99m sestamibi whole-body scans in diagnosis of metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: A comparison with iodine-131 and thallium-201 whole-body scans. Eur J Nucl Med 21:980-983.
49. Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan A, Slizofski W 1995 Clinical utility of technetium-99m methoxyisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Eur J Nuclear Med 22:1330-1338.
50. Nemec J, Nyvltora O, Blazek T, et al. 1996 Positive thyroid cancer scintigraphy using technetium-99m methoxyisobutylisonitrile. Eur J Nuclear Med 23:69-71.
51. 67Ga in the diagnosis of anaplastic carcinoma and lymphoma of the thyroid. Radiology 141:491-497.
52. Castillo LA, Yeh SDJ, Leeper RD, Benua RS 1980 Bone scans in bone metastases from functioning thyroid carcinoma. Clin Nucl Med 5:200-209.
53. DeGroot LJ, Reilly M 1984 Use of isotope bone scans and skeletal survey x-rays in the follow-up of patients with thyroid carcinoma. J Endocrinol Invest 7:175-179.
54. Scott GC, Meier DA, Dickinson CZ 1995 Cervical lymph node metastases of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate, and iodine-131-sodium iodide. J Nucl Med 36:1843-1845.
55. Grunwald F, Schomburg A, Bender H, et al. 1996 Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nuclear Med 23:312-319.